USA flag logo/image

An Official Website of the United States Government

High Multiplexing Liquid Array Assay Platform

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
93741
Program Year/Program:
2009 / SBIR
Agency Tracking Number:
EB008616
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ARRAYOMICS, INC.
ARRAYOMICS, INC. 9909 HIBERT ST, STE A SAN DIEGO, CA -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2009
Title: High Multiplexing Liquid Array Assay Platform
Agency: HHS
Contract: 1R43EB008616-01A1
Award Amount: $99,999.00
 

Abstract:

DESCRIPTION (provided by applicant): The aim of this project is to expand the capabilities of a novel liquid array' platform, based on Encoded Sortable Particle (ESP) technology to make it cost and performance compatible with high multiplex assays. ESPs are optically-encoded microfabricated particles that can be manipulated using magnetic force. We will adapt our ESP-based liquid array system, which has already been successfully applied in the low multiplex space, to accommodate assays of 100,000-plex or more. ESP technology has broad applicability and should be a valuable tool in the diagnosis, prognosis, and characterization of a variety of disease states, including cancer, heart disease, arthritis and inflammatory diseases, kidney disease, liver disease , allergic responses, and infectious diseases (e.g. HIV). PUBLIC HEALTH RELEVANCE: ESP technology as applied to the high multiplex assay space will provide a broad platform for many different kinds of assays. The ESP platform is intrinsically versatile, an d has the potential to be used in basic biomedical research, as well as high- throughput discovery and clinical diagnostics. The ability to control the particles magnetically (in a manner significantly different from magnetic beads) is a significant advant age. This technology should be useful in the diagnosis and prognosis of a variety of disease states, including cancer, heart disease, arthritis and inflammatory diseases, kidney disease, and infectious diseases (e.g. HIV).

Principal Investigator:

David M. Rothwarf
8582452435
DROTHWARF@ARRAYOMICS.COM

Business Contact:

Christopher Herold
drothwarf@arrayomics.com
Small Business Information at Submission:

ARRAYOMICS, INC.
ARRAYOMICS, INC. 9909 HIBERT ST, STE A SAN DIEGO, CA 92131

EIN/Tax ID: 320005243
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No